Literature DB >> 24419292

Risk factors and management of osteoporosis in inflammatory bowel disease.

Laura E Targownik1, Charles N Bernstein, William D Leslie.   

Abstract

PURPOSE OF REVIEW: To provide a synopsis on established and new research evaluating bone disease in patients with inflammatory bowel disease (IBD). RECENT
FINDINGS: Persons with IBD, including Crohn's disease and ulcerative colitis are believed to be at high risk for osteoporosis and fracture. As osteoporosis is clinically silent and persons with IBD are not universally screened, the burden of bone disease in IBD has been difficult to accurately assess. It is also unclear whether bone disease is due to inflammatory activity, medication use, poor nutrient intake/absorption, or body habitus characteristics. Recent studies using population-wide databases of bone mineral density (BMD) analyses suggest that Crohn's disease is responsible for a small effect on BMD after adjusting for other risk factors for low BMD, whereas ulcerative colitis does not appear to confer an independent risk. Furthermore, IBD does not appear to be a risk for overall fracture once controlling for factors which are associated with both IBD and fracture risk. The ability to assess BMD on incidentally performed computed tomography scans may allow detection of low BMD in IBD patients.
SUMMARY: Although reduced BMD and fracture are more common in persons with IBD, the precise burden is not well characterized. Also, the relative impact of IBD-associated factors and IBD-specific inflammation on bone health is still uncertain.

Entities:  

Mesh:

Year:  2014        PMID: 24419292     DOI: 10.1097/MOG.0000000000000037

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  24 in total

1.  Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.

Authors:  C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

2.  Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.

Authors:  Vijayababu M Radhakrishnan; Pawel Kojs; Rajalakshmy Ramalingam; Monica T Midura-Kiela; Peter Angeli; Pawel R Kiela; Fayez K Ghishan
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

3.  Indian Society of Gastroenterology consensus statements on Crohn's disease in India.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Vineet Ahuja; Uday C Ghoshal; Venkataraman Jayanthi; Benjamin Perakath; Philip Abraham; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra Desai; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Mathew Philip; Anna Pulimood; Amarender S Puri; Gautam Ray; Shivaram P Singh; Ajit Sood; Venkatraman Subramanian
Journal:  Indian J Gastroenterol       Date:  2015-03-14

Review 4.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

5.  Sex-Specific Issues in Inflammatory Bowel Disease.

Authors:  Elizabeth Rosenblatt; Sunanda Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-09

6.  Opportunistic screening for bone disease using abdominal CT scans obtained for other reasons in newly diagnosed IBD patients.

Authors:  D Rebello; D Anjelly; D J Grand; J T Machan; M D Beland; M S Furman; J Shapiro; N LeLeiko; B E Sands; M Mallette; R Bright; H Moniz; M Merrick; S A Shah
Journal:  Osteoporos Int       Date:  2018-03-08       Impact factor: 4.507

Review 7.  Managing osteoporosis in ulcerative colitis: something new?

Authors:  Luca Petruccio Piodi; Alessandro Poloni; Fabio Massimo Ulivieri
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 8.  Risk factors for osteoporosis in inflammatory bowel disease patients.

Authors:  Carla Andrade Lima; Andre Castro Lyra; Raquel Rocha; Genoile Oliveira Santana
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

9.  High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients.

Authors:  Judith Haschka; Simon Hirschmann; Arnd Kleyer; Matthias Englbrecht; Francesca Faustini; David Simon; Camille P Figueiredo; Louis Schuster; Christian Muschitz; Roland Kocijan; Heinrich Resch; Raja Atreya; Jürgen Rech; Markus F Neurath; Georg Schett
Journal:  J Crohns Colitis       Date:  2016-01-27       Impact factor: 9.071

Review 10.  Advances in nutritional therapy in inflammatory bowel diseases: Review.

Authors:  Andrzej Wędrychowicz; Andrzej Zając; Przemysław Tomasik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.